Skip to content

Understanding Your Diagnostic Test: Purpose, Procedure, and Results

Published: August 9, 2026Updated: August 16, 2026

A genetic test that analyzes the BBS2 gene to detect specific mutations associated with Bardet-Biedl syndrome.

Quick summary

{"This test looks for mutations in the BBS2 gene that cause Bardet-Biedl syndrome","A blood or tissue sample is collected and sent to a specialized laboratory for analysis","Results help confirm a diagnosis or identify carriers of the gene mutation","The test uses molecular genetics methods to examine the DNA sequence","Results typically take several weeks to process"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
48598-7
Short code
BBS2MUT
Synonyms
BBS2 gene Mut Anl Bld/T
Category
chemistry
Sample
whole-blood
Container
EDTA (purple-top) blood collection tube for whole blood; sterile container for tissue specimens
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
molgen
CPT
81405
SNOMED
53034004
Specimen volume
3-5 mL whole blood in EDTA tube; 5-10 mg tissue in sterile transport medium
Stability
Whole blood: stable at 2-8°C for up to 7 days; for longer storage, freeze at -20°C or below. Tissue: stable in transport medium at 2-8°C for 48 hours; freeze at -80°C for extended storage. Avoid repeated freeze-thaw cycles. Extract DNA upon receipt for long-term stability.
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
336–720 hours
Order
routine

This test is a diagnostic procedure that helps your healthcare provider evaluate how your body is functioning and look for signs of illness. It is performed on a sample collected from your body, such as blood, urine, or tissue, and the findings are interpreted together with your symptoms, medical history, and physical examination.

The BBS2 gene targeted mutation analysis is a specialized genetic test that examines the BBS2 gene to look for specific mutations (changes) known to cause Bardet-Biedl syndrome (BBS). Bardet-Biedl syndrome is a rare genetic disorder that affects multiple body systems, including vision, hearing, kidney function, and obesity. This test uses molecular genetics methods to analyze your DNA and determine if you have mutations in the BBS2 gene.

Your healthcare provider may order this test to help diagnose a medical condition, monitor a disease you already have, screen for risk factors, or check how well a treatment is working. It can also be used to rule out certain causes of your symptoms before deciding whether additional testing or therapy is needed.

Your healthcare provider may order this test if you or your child show symptoms of Bardet-Biedl syndrome, such as vision problems, extra fingers or toes, obesity, kidney abnormalities, or learning difficulties. The test is also used to confirm a diagnosis when BBS is suspected, to determine if family members are carriers of the mutation, and to provide genetic counseling for families affected by this condition. Additionally, this test may be used for prenatal diagnosis in families with a known BBS2 mutation.

A trained healthcare professional collects the required sample, most often by drawing a small amount of blood from a vein in your arm or by asking you to provide a urine specimen. The sample is then sent to a laboratory, where specialized equipment and trained staff analyze it, and the report is returned to your provider, usually within a few days.

The test requires a sample of whole blood or tissue. For a blood test, a healthcare professional will draw a small amount of blood from a vein in your arm. For tissue samples, a biopsy may be taken from the affected area. The sample is then sent to a specialized genetics laboratory where scientists extract the DNA and analyze the BBS2 gene using advanced molecular techniques to identify specific mutations. The test looks for known disease-causing mutations rather than sequencing the entire gene.

Results are compared with established reference ranges and reviewed alongside your symptoms and history. Values within the normal range generally suggest that no abnormality was detected, while values higher or lower than expected may point to a condition that requires closer attention, monitoring, or additional confirmatory testing.

A positive result means that a known disease-causing mutation was found in the BBS2 gene, which supports a diagnosis of Bardet-Biedl syndrome. A negative result means that the specific mutations tested were not found, but it does not completely rule out BBS as there may be other genes or unknown mutations involved. Your healthcare provider and a genetic counselor will help interpret your results in the context of your symptoms and family history. It is important to discuss your results thoroughly with a genetics specialist.

The risks are usually minimal and may include brief pain or bruising at the needle site, lightheadedness, or, rarely, infection or bleeding. No test is perfect: false-positive and false-negative results can occur, medications and recent meals can influence findings, and abnormal results often need follow-up testing before a diagnosis is confirmed.

The risks of this test are minimal and similar to routine blood draws, including slight pain, bruising, or bleeding at the puncture site. There is also a possibility of finding unexpected results, such as variants of uncertain significance, which are genetic changes whose effect on health is not yet known. In rare cases, the test may need to be repeated if the sample is insufficient. Genetic testing may also have implications for family members, and counseling is recommended to discuss these considerations.

Reference range

No pathogenic mutations detected in the analyzed regions of the BBS2 gene. Reference results indicate the absence of targeted disease-associated variants; clinical correlation is recommended.N/A

Specimen: whole-blood

No special preparation or fasting is required. Patients should provide informed consent for genetic testing. A detailed family history and clinical evaluation are recommended to guide interpretation. Genetic counseling is advised before and after testing.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The BBS2 gene mutation analysis is clinically significant for diagnosing Bardet-Biedl syndrome, a rare autosomal recessive disorder. Identification of BBS2 mutations helps confirm the diagnosis, guides management and treatment, and provides information for family planning. The test is particularly valuable when clinical features suggest BBS but the diagnosis is uncertain. Knowledge of the specific mutation can also help predict disease progression and associated complications, allowing for proactive monitoring and intervention.

Frequently asked questions

How long does it take to get results?
Results from BBS2 gene mutation analysis typically take 2-4 weeks to process. This is because the test requires specialized laboratory techniques and careful analysis by trained geneticists. Your healthcare provider will contact you when results are available.
Do I need to fast before this test?
No, fasting is not required for this genetic test. You can eat and drink normally before your blood draw. However, always follow any specific instructions given by your healthcare provider.
Will my insurance cover this genetic test?
Coverage varies depending on your insurance plan and the reason for testing. Many insurance companies cover genetic testing when it is medically necessary. It is recommended to check with your insurance provider beforehand to understand your coverage and any potential out-of-pocket costs.
Can children have this test?
Yes, children can undergo BBS2 gene mutation testing. If a child shows symptoms of Bardet-Biedl syndrome or has a family history of the condition, a healthcare provider may recommend genetic testing. For children, the test is typically performed on a blood sample, and parents or guardians will need to provide consent.
What is the difference between diagnostic testing and carrier testing?
Diagnostic testing is performed when an individual has symptoms of Bardet-Biedl syndrome to confirm or rule out the diagnosis. Carrier testing is performed on individuals without symptoms to determine if they carry one copy of a BBS2 mutation. Carrier testing is particularly important for family members of someone diagnosed with BBS or for couples planning pregnancy who have a family history of the condition.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy